Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

.gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

HTTPS

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Clinicalinfo.HIV.gov logo.
In affiliation with HIV.gov
Main navigation
  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • English
  • Español (Spanish)
  1. Home
  2. Search Results
Search Results 721 – 740 of 3231
Glecaprevir / Pibrentasvir
https://clinicalinfo.hiv.gov/drugs/glecaprevir-pibrentasvir/fda-label
Glecaprevir / Pibrentasvir
https://clinicalinfo.hiv.gov/drugs/glecaprevir-pibrentasvir/patient
Glecaprevir / Pibrentasvir
https://clinicalinfo.hiv.gov/drugs/glecaprevir-pibrentasvir/patient
Hepatitis A and Hepatitis B (Recombinant) Vaccine
https://clinicalinfo.hiv.gov/drugs/hepatitis-and-hepatitis-b-recombinant-vaccine/fda-label
Hepatitis A and Hepatitis B (Recombinant) Vaccine
https://clinicalinfo.hiv.gov/drugs/hepatitis-and-hepatitis-b-recombinant-vaccine/patient
Vacuna contra la hepatitis A y la hepatitis B (recombinante)
https://clinicalinfo.hiv.gov/drugs/hepatitis-and-hepatitis-b-recombinant-vaccine/patient
Hepatitis B Vaccine
https://clinicalinfo.hiv.gov/drugs/hepatitis-b-vaccine/fda-label
Hepatitis B Vaccine
https://clinicalinfo.hiv.gov/drugs/hepatitis-b-vaccine/patient
Vacuna contra la hepatitis B
https://clinicalinfo.hiv.gov/drugs/hepatitis-b-vaccine/patient
Human Papillomavirus 9-Valent Vaccine, Recombinant
https://clinicalinfo.hiv.gov/drugs/human-papillomavirus-9-valent-vaccine-recombinant/fda-label
Human Papillomavirus 9-Valent Vaccine, Recombinant
https://clinicalinfo.hiv.gov/drugs/human-papillomavirus-9-valent-vaccine-recombinant/patient
Vacuna 9-valente recombinante contra los virus del papiloma humano
https://clinicalinfo.hiv.gov/drugs/human-papillomavirus-9-valent-vaccine-recombinant/patient
Ibalizumab-uiyk
https://clinicalinfo.hiv.gov/drugs/ibalizumab-uiyk/fda-label
Ibalizumab-uiyk
https://clinicalinfo.hiv.gov/drugs/ibalizumab-uiyk/patient
Ibalizumab-uiyk
https://clinicalinfo.hiv.gov/drugs/ibalizumab-uiyk/patient
Imiquimod
https://clinicalinfo.hiv.gov/drugs/imiquimod/fda-label
Imiquimod
https://clinicalinfo.hiv.gov/drugs/imiquimod/patient
Imiquimod
https://clinicalinfo.hiv.gov/drugs/imiquimod/patient
Isoniazid
https://clinicalinfo.hiv.gov/drugs/isoniazid/fda-label
Isoniazid
https://clinicalinfo.hiv.gov/drugs/isoniazid/patient

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Current page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • …
  • Next page ›
  • Last page »

CONNECT WITH US

Footer menu

  • Home
  • About
  • Guidelines
  • Drug Database
  • Glossary
  • News
  • Resources
  • Contact Us
  • Sponsors
  • Nondiscrimination Notice
  • Accessibility
  • Disclaimers
  • Sitemap
  • Privacy Policy
  • HHS Vulnerability Disclosure

External links

  • HIVinfo.NIH.gov
  • HHS.gov
  • NIH.gov
  • Players & Viewers
  • HHS 508
  • HHS Privacy Policy
  • Whitehouse.gov
  • USA.gov
  • Freedom of Information Act

Provided in collaboration with NIH’s Office of AIDS Research.